Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
about
sameAs
Artemisinin-resistant malaria: research challenges, opportunities, and public health implicationsCombating poor-quality anti-malarial medicines: a call to actionThe role of early detection and treatment in malaria eliminationMalaria Diagnosis Across the International Centers of Excellence for Malaria Research: Platforms, Performance, and StandardizationThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceInterventions to combat or prevent drug counterfeiting: a systematic reviewTowards the just and sustainable use of antibioticsQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainTechnologies for detecting falsified and substandard drugs in low and middle-income countries.Evaluation of a new handheld instrument for the detection of counterfeit artesunate by visual fluorescence comparisonEffective coverage and systems effectiveness for malaria case management in sub-Saharan African countriesQuality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, NigeriaPharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA StudyThe Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in TanzaniaResponding to the pandemic of falsified medicines.Drug resistance in eukaryotic microorganisms.Stopping murder by medicine: introducing the Model Law on Medicine Crime.The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives.Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern MalawiMalaria control in South Sudan, 2006-2013: strategies, progress and challenges.Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in KenyaApplication of loop analysis for evaluation of malaria control interventions.Malaria or flu? A case report of misdiagnosis.A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Anti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findings.Exploring the role of socioeconomic factors in the development and spread of anti-malarial drug resistance: a qualitative study.Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countriesDonor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin.The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.Treating severe malaria in pregnancy: a review of the evidenceArtemisinin resistance--modelling the potential human and economic costs.Genome wide in silico analysis of Plasmodium falciparum phosphatome.Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns.Paper analytical devices for fast field screening of beta lactam antibiotics and antituberculosis pharmaceuticals.In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitorsNew Italian guidelines for malaria prophylaxis in travellers to endemic areas.Current scenario of spurious and substandard medicines in India: a systematic review.
P2860
Q21032532-C2BA0EFC-EB32-4958-94AB-256C8F89A014Q24658634-872744C1-120C-4BFB-AE57-15A46E5387BAQ26740068-41D93F28-E1E0-41D4-A189-CD9F47FD1845Q26799721-5FA96E27-6F3D-4FCF-AC68-31A610B9B9E6Q26828002-FB7081BD-8FDC-452A-A900-7BDFAC173DA2Q27010468-CF953CE3-46F8-4226-91D8-0500DA2DEA82Q28067846-3A24AFE5-0ACA-4C7A-9771-41F4AEFCDE7FQ28538830-605CFCBE-AA20-4A16-AE58-E41B83F250C0Q28541540-3B428AE5-41CD-488D-9F8E-F08F3711033CQ28544869-51F285C3-4B3B-46A3-BC82-E5F97EBC4CC0Q28547444-214E57BA-0917-4A48-AA7E-8D6DD3B1E074Q28547513-3DEDEEBB-7F9D-481F-B804-B453C2C7597FQ28551981-DA6DC430-C078-4363-B705-443E4990B769Q28553535-BF0DF582-0B28-496D-A576-59080DABE2ADQ30062161-51506E9A-C1D3-4BD2-91BA-A8B0D43D45A6Q30248243-339FCEDB-97EA-4E9B-9229-EF408C2FA5FCQ30373987-2AC8D3BB-685C-49EA-A5BF-2AB9D05F3CADQ30373989-74AC0E86-426B-485E-B588-0947E65FE598Q30377168-97181677-64D9-4245-B651-683D1DB4932FQ30392910-18F9DB79-D2ED-4C09-85A2-6D4C77C72A2AQ30486867-A4053425-61E3-4A5C-BF60-2377BAFF0B8CQ31076495-047CC41E-81A3-4411-A260-FC667AFEF71BQ33597968-C43E4B91-4D72-49E2-9472-1B143B8BD15EQ33628983-52E77473-7772-43E7-8BBA-1B496E7B8685Q33636843-2037D98D-C9BF-403F-8CBE-EC8E2EA0A692Q33655603-BC1EC16C-546E-4366-8EAD-9490A5C618E7Q33691830-0B6B2C43-2A8A-4C1D-ADC6-6C9D6E2378E9Q33706538-0F256073-7466-4E53-9F07-3C1225300EB4Q33726606-95FE9958-8D4C-4193-9D4F-75723E9F6A6DQ33892227-32F738DF-838A-490F-87B7-EC024561877AQ33960081-A0DCD67B-89BB-4C14-83A0-D9955A02BD89Q34329292-74B308A6-DF08-4324-AF04-F6478699F934Q34456393-581BA6FE-851B-4431-99C6-0E7F16D54ACBQ34623414-D9AF6BB8-6919-4C11-8114-32891092D9B2Q34637025-85257E3D-ACA4-4F99-84A0-3517B27CE484Q34652195-0A371500-3DAB-4CC2-BFFD-49663589FF92Q34750498-976726BD-4EB9-4CB2-817F-43A5E1EF6E6DQ34785012-AF64E247-C97A-4B1F-9D6A-44D14C2A80AAQ35068993-BF827A89-5666-4C2E-8D48-68662B3E0859Q35166222-641981BE-005D-4F64-8649-901B20E007C1
P2860
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@ast
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@en
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@nl
type
label
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@ast
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@en
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@nl
altLabel
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
@en
prefLabel
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@ast
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@en
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
@nl
P2093
P1476
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
@en
P2093
Gaurvika M L Nayyar
James Herrington
Joel G Breman
P304
P356
10.1016/S1473-3099(12)70064-6
P577
2012-06-01T00:00:00Z